TY - JOUR
T1 - Unexpected role of TNF-α in graft versus host reaction (GVHR)
T2 - Donor-derived TNF-α suppresses GVHR via inhibition of IFN-γ -dependent donor type-1 immunity
AU - Yamamoto, Satoshi
AU - Tsuji, Takemasa
AU - Matsuzaki, Junko
AU - Zhange, Yue
AU - Chamoto, Kenji
AU - Kosaka, Akemi
AU - Togashi, Yuji
AU - Sekikawa, Kenji
AU - Sawada, Ken Ichi
AU - Takeshima, Tsuguhide
AU - Koike, Takao
AU - Nishimura, Takashi
N1 - Funding Information:
We would like to thank Dr Luc Van Kaer (Vanderbilt University School of Medicine, Nashville, TN) for reviewing this paper. We thank Ms Shinobu Miyamoto for secretarial assistance. This work was supported in part by a grant-in-aid for Science Research on Priority Areas, Scientific Research (B) and Millennium Project from the Ministry of Education, Science, Technology, Sports, and Culture with the Long-Range Research Initiative Project of Japan Chemical Industry Association.
PY - 2004/6
Y1 - 2004/6
N2 - Graft versus host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation, leading to significant morbidity and mortality. Host-derived TNF-α play a role in the induction of allo-reactive donor T cell activation and the pathogenesis of GVHD. On the other hand, the precise role of donor-derived TNF-α in GVHD remains unclear. To elucidate this issue, we designed an acute GVHD model using (B6×D2) F1 recipient mice transferred with spleen cells derived from either wild-type or TNF-α-/- C57BL/6 mice. Surprisingly, we found that spleen cells from TNF-α-/- mice induce more severe graft versus host reaction (GVHR) than wild-type spleen cells upon transfer into B6D2F1 mice. Transplantation of TNF-α-/- mouse spleen cells was associated with enhanced anti-host CTL generation and augmented deletion of host cells. Moreover, mice receiving TNF-α-/- cells showed significantly higher levels of serum IFN-γ, which was mainly produced by donor CD8+ T cells. We also demonstrated that TNF-α deficiency in donor spleen cells caused a marked elevation of TNF-α producing capacity by LPS-stimulated host macrophages. Such enhanced GVHR was completely prevented by using TNF-α-/-TNF-γ-/- splenic cells. Our findings demonstrate, for the first time, that donor-derived TNF-α suppress GVHR by inhibiting IFN-γ -dependent donor type-1 immunity which is essential for host TNF-α elevation.
AB - Graft versus host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation, leading to significant morbidity and mortality. Host-derived TNF-α play a role in the induction of allo-reactive donor T cell activation and the pathogenesis of GVHD. On the other hand, the precise role of donor-derived TNF-α in GVHD remains unclear. To elucidate this issue, we designed an acute GVHD model using (B6×D2) F1 recipient mice transferred with spleen cells derived from either wild-type or TNF-α-/- C57BL/6 mice. Surprisingly, we found that spleen cells from TNF-α-/- mice induce more severe graft versus host reaction (GVHR) than wild-type spleen cells upon transfer into B6D2F1 mice. Transplantation of TNF-α-/- mouse spleen cells was associated with enhanced anti-host CTL generation and augmented deletion of host cells. Moreover, mice receiving TNF-α-/- cells showed significantly higher levels of serum IFN-γ, which was mainly produced by donor CD8+ T cells. We also demonstrated that TNF-α deficiency in donor spleen cells caused a marked elevation of TNF-α producing capacity by LPS-stimulated host macrophages. Such enhanced GVHR was completely prevented by using TNF-α-/-TNF-γ-/- splenic cells. Our findings demonstrate, for the first time, that donor-derived TNF-α suppress GVHR by inhibiting IFN-γ -dependent donor type-1 immunity which is essential for host TNF-α elevation.
KW - CTL
KW - Cytokines
KW - Graft vs host disease
KW - Th1/Th2 cells
KW - Transplantation
UR - http://www.scopus.com/inward/record.url?scp=2942718569&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2942718569&partnerID=8YFLogxK
U2 - 10.1093/intimm/dxh082
DO - 10.1093/intimm/dxh082
M3 - Article
C2 - 15126416
AN - SCOPUS:2942718569
SN - 0953-8178
VL - 16
SP - 811
EP - 817
JO - International Immunology
JF - International Immunology
IS - 6
ER -